Bain Capital Life Sciences Investors, LLC Cabaletta Bio, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $298 Million
- Q1 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,760,888 shares of CABA stock, worth $3.67 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
2,760,888
Previous 2,760,888
-0.0%
Holding current value
$3.67 Million
Previous $6.07 Million
36.82%
% of portfolio
1.29%
Previous 1.64%
Shares
4 transactions
Others Institutions Holding CABA
# of Institutions
86Shares Held
43MCall Options Held
154KPut Options Held
192K-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$6.33 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$5.28 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$4.83 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.45MShares$4.59 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...